Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-21-011207
Filing Date
2021-02-03
Accepted
2021-02-03 06:15:31
Documents
1
Group Members
MALIN CORP PLC

Document Format Files

Seq Description Document Type Size
1 SC 13G tm215030d1_sc13g.htm SC 13G 54702
  Complete submission text file 0001104659-21-011207.txt   56289
Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Subject) CIK: 0001661460 (see all company filings)

IRS No.: 472846548 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91606 | Film No.: 21584128
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2 HARBOUR SQUARE CROFTON ROAD DUN LAOGHAIRE, CO, DUBLIN L2 ----
Business Address 2 HARBOUR SQUARE CROFTON ROAD DUN LAOGHAIRE, CO, DUBLIN L2 ---- 353 1 901 5701
Malin Life Sciences Holdings Ltd (Filed by) CIK: 0001685138 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: SC 13G